#Compounding pharmacies

2 stories

Research April 7, 2026 · View digest

The New Yorker Investigates the Gray-Market Peptide Injection Craze

Physician-journalist Dhruv Khullar traces the peptide movement from CrossFit communities to mainstream wellness, documenting contamination (lead in BPC-157, endotoxins in TB-500), lack of human trials, and RFK Jr.'s attacks on FDA restrictions.

Regulatory April 4, 2026 · View digest

RFK Jr. May Reverse FDA Peptide Ban — Former Officials Push Back

ProPublica reveals the potential reversal of the FDA's 2023 ban on 19 compounded peptides. Three former FDA officials, including former acting commissioner Janet Woodcock, say RFK Jr. mischaracterized their work and that documented safety concerns supported the ban.